United States Specialty Injectable Generics Market Report 2017

November 2017 | 108 pages | ID: U6F888F0053EN
QYResearch

Abstracts

In this report, the United States Specialty Injectable Generics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Specialty Injectable Generics in these regions, from 2012 to 2022 (forecast).

United States Specialty Injectable Generics market competition by top manufacturers/players, with Specialty Injectable Generics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Fresenius
• Mylan N.V.
• Teva Pharmaceutical
• Hikma Pharmaceuticals
• Novartis AG
• Uman Pharma
• Baxter
• Par Pharmaceutical
• Sagent Pharmaceuticals
• Teligent

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Type I
• Type II

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Oncology
• Cardiovascular
• Central Nervous System
• Infectious Diseases
• Autoimmune Disorders

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Specialty Injectable Generics Market Report 2017

1 SPECIALTY INJECTABLE GENERICS OVERVIEW

1.1 Product Overview and Scope of Specialty Injectable Generics
1.2 Classification of Specialty Injectable Generics by Product Category
  1.2.1 United States Specialty Injectable Generics Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Specialty Injectable Generics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3
  1.2.4
1.3 United States Specialty Injectable Generics Market by Application/End Users
  1.3.1 United States Specialty Injectable Generics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Oncology
  1.3.3 Cardiovascular
  1.3.4 Central Nervous System
  1.3.5 Infectious Diseases
  1.3.6 Autoimmune Disorders
1.4 United States Specialty Injectable Generics Market by Region
  1.4.1 United States Specialty Injectable Generics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Specialty Injectable Generics Status and Prospect (2012-2022)
  1.4.3 Southwest Specialty Injectable Generics Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Specialty Injectable Generics Status and Prospect (2012-2022)
  1.4.5 New England Specialty Injectable Generics Status and Prospect (2012-2022)
  1.4.6 The South Specialty Injectable Generics Status and Prospect (2012-2022)
  1.4.7 The Midwest Specialty Injectable Generics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Specialty Injectable Generics (2012-2022)
  1.5.1 United States Specialty Injectable Generics Sales and Growth Rate (2012-2022)
  1.5.2 United States Specialty Injectable Generics Revenue and Growth Rate (2012-2022)

2 UNITED STATES SPECIALTY INJECTABLE GENERICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Specialty Injectable Generics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Specialty Injectable Generics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Specialty Injectable Generics Average Price by Players/Suppliers (2012-2017)
2.4 United States Specialty Injectable Generics Market Competitive Situation and Trends
  2.4.1 United States Specialty Injectable Generics Market Concentration Rate
  2.4.2 United States Specialty Injectable Generics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Specialty Injectable Generics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES SPECIALTY INJECTABLE GENERICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Specialty Injectable Generics Sales and Market Share by Region (2012-2017)
3.2 United States Specialty Injectable Generics Revenue and Market Share by Region (2012-2017)
3.3 United States Specialty Injectable Generics Price by Region (2012-2017)

4 UNITED STATES SPECIALTY INJECTABLE GENERICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Specialty Injectable Generics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Specialty Injectable Generics Revenue and Market Share by Type (2012-2017)
4.3 United States Specialty Injectable Generics Price by Type (2012-2017)
4.4 United States Specialty Injectable Generics Sales Growth Rate by Type (2012-2017)

5 UNITED STATES SPECIALTY INJECTABLE GENERICS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Specialty Injectable Generics Sales and Market Share by Application (2012-2017)
5.2 United States Specialty Injectable Generics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES SPECIALTY INJECTABLE GENERICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Specialty Injectable Generics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Fresenius
  6.2.2 Specialty Injectable Generics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Fresenius Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Mylan N.V.
  6.3.2 Specialty Injectable Generics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Mylan N.V. Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Teva Pharmaceutical
  6.4.2 Specialty Injectable Generics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Teva Pharmaceutical Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Hikma Pharmaceuticals
  6.5.2 Specialty Injectable Generics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Hikma Pharmaceuticals Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Novartis AG
  6.6.2 Specialty Injectable Generics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novartis AG Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Uman Pharma
  6.7.2 Specialty Injectable Generics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Uman Pharma Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Baxter
  6.8.2 Specialty Injectable Generics Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Baxter Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Par Pharmaceutical
  6.9.2 Specialty Injectable Generics Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Par Pharmaceutical Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Sagent Pharmaceuticals
  6.10.2 Specialty Injectable Generics Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Sagent Pharmaceuticals Specialty Injectable Generics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Teligent

7 SPECIALTY INJECTABLE GENERICS MANUFACTURING COST ANALYSIS

7.1 Specialty Injectable Generics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Specialty Injectable Generics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Specialty Injectable Generics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Specialty Injectable Generics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SPECIALTY INJECTABLE GENERICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Specialty Injectable Generics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Specialty Injectable Generics Sales Volume Forecast by Type (2017-2022)
11.3 United States Specialty Injectable Generics Sales Volume Forecast by Application (2017-2022)
11.4 United States Specialty Injectable Generics Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Specialty Injectable Generics
Figure United States Specialty Injectable Generics Market Size (K Units) by Type (2012-2022)
Figure United States Specialty Injectable Generics Sales Volume Market Share by Type (Product Category) in 2016
Figure Type I Product Picture
Figure Type II Product Picture
Figure United States Specialty Injectable Generics Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Specialty Injectable Generics by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Central Nervous System Examples
Table Key Downstream Customer in Central Nervous System
Figure Infectious Diseases Examples
Table Key Downstream Customer in Infectious Diseases
Figure Autoimmune Disorders Examples
Table Key Downstream Customer in Autoimmune Disorders
Figure United States Specialty Injectable Generics Market Size (Million USD) by Region (2012-2022)
Figure The West Specialty Injectable Generics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Specialty Injectable Generics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Specialty Injectable Generics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Specialty Injectable Generics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Specialty Injectable Generics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Specialty Injectable Generics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Specialty Injectable Generics Sales (K Units) and Growth Rate (2012-2022)
Figure United States Specialty Injectable Generics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Specialty Injectable Generics Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Specialty Injectable Generics Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Specialty Injectable Generics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Specialty Injectable Generics Sales Share by Players/Suppliers
Figure 2017 United States Specialty Injectable Generics Sales Share by Players/Suppliers
Figure United States Specialty Injectable Generics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Specialty Injectable Generics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Specialty Injectable Generics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Specialty Injectable Generics Revenue Share by Players/Suppliers
Figure 2017 United States Specialty Injectable Generics Revenue Share by Players/Suppliers
Table United States Market Specialty Injectable Generics Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Specialty Injectable Generics Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Specialty Injectable Generics Market Share of Top 3 Players/Suppliers
Figure United States Specialty Injectable Generics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Specialty Injectable Generics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Specialty Injectable Generics Product Category
Table United States Specialty Injectable Generics Sales (K Units) by Region (2012-2017)
Table United States Specialty Injectable Generics Sales Share by Region (2012-2017)
Figure United States Specialty Injectable Generics Sales Share by Region (2012-2017)
Figure United States Specialty Injectable Generics Sales Market Share by Region in 2016
Table United States Specialty Injectable Generics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Specialty Injectable Generics Revenue Share by Region (2012-2017)
Figure United States Specialty Injectable Generics Revenue Market Share by Region (2012-2017)
Figure United States Specialty Injectable Generics Revenue Market Share by Region in 2016
Table United States Specialty Injectable Generics Price (USD/Unit) by Region (2012-2017)
Table United States Specialty Injectable Generics Sales (K Units) by Type (2012-2017)
Table United States Specialty Injectable Generics Sales Share by Type (2012-2017)
Figure United States Specialty Injectable Generics Sales Share by Type (2012-2017)
Figure United States Specialty Injectable Generics Sales Market Share by Type in 2016
Table United States Specialty Injectable Generics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Specialty Injectable Generics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Specialty Injectable Generics by Type (2012-2017)
Figure Revenue Market Share of Specialty Injectable Generics by Type in 2016
Table United States Specialty Injectable Generics Price (USD/Unit) by Types (2012-2017)
Figure United States Specialty Injectable Generics Sales Growth Rate by Type (2012-2017)
Table United States Specialty Injectable Generics Sales (K Units) by Application (2012-2017)
Table United States Specialty Injectable Generics Sales Market Share by Application (2012-2017)
Figure United States Specialty Injectable Generics Sales Market Share by Application (2012-2017)
Figure United States Specialty Injectable Generics Sales Market Share by Application in 2016
Table United States Specialty Injectable Generics Sales Growth Rate by Application (2012-2017)
Figure United States Specialty Injectable Generics Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Specialty Injectable Generics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Specialty Injectable Generics Sales Growth Rate (2012-2017)
Figure Pfizer Specialty Injectable Generics Sales Market Share in United States (2012-2017)
Figure Pfizer Specialty Injectable Generics Revenue Market Share in United States (2012-2017)
Table Fresenius Basic Information List
Table Fresenius Specialty Injectable Generics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Fresenius Specialty Injectable Generics Sales Growth Rate (2012-2017)
Figure Fresenius Specialty Injectable Generics Sales Market Share in United States (2012-2017)
Figure Fresenius Specialty Injectable Generics Revenue Market Share in United States (2012-2017)
Table Mylan N.V. Basic Information List
Table Mylan N.V. Specialty Injectable Generics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mylan N.V. Specialty Injectable Generics Sales Growth Rate (2012-2017)
Figure Mylan N.V. Specialty Injectable Generics Sales Market Share in United States (2012-2017)
Figure Mylan N.V. Specialty Injectable Generics Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Specialty Injectable Generics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Specialty Injectable Generics Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Specialty Injectable Generics Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Specialty Injectable Generics Revenue Market Share in United States (2012-2017)
Table Hikma Pharmaceuticals Basic Information List
Table Hikma Pharmaceuticals Specialty Injectable Generics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hikma Pharmaceuticals Specialty Injectable Generics Sales Growth Rate (2012-2017)
Figure Hikma Pharmaceuticals Specialty Injectable Generics Sales Market Share in United States (2012-2017)
Figure Hikma Pharmaceuticals Specialty Injectable Generics Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Specialty Injectable Generics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG Specialty Injectable Generics Sales Growth Rate (2012-2017)
Figure Novartis AG Specialty Injectable Generics Sales Market Share in United States (2012-2017)
Figure Novartis AG Specialty Injectable Generics Revenue Market Share in United States (2012-2017)
Table Uman Pharma Basic Information List
Table Uman Pharma Specialty Injectable Generics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Uman Pharma Specialty Injectable Generics Sales Growth Rate (2012-2017)
Figure Uman Pharma Specialty Injectable Generics Sales Market Share in United States (2012-2017)
Figure Uman Pharma Specialty Injectable Generics Revenue Market Share in United States (2012-2017)
Table Baxter Basic Information List
Table Baxter Specialty Injectable Generics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Baxter Specialty Injectable Generics Sales Growth Rate (2012-2017)
Figure Baxter Specialty Injectable Generics Sales Market Share in United States (2012-2017)
Figure Baxter Specialty Injectable Generics Revenue Market Share in United States (2012-2017)
Table Par Pharmaceutical Basic Information List
Table Par Pharmaceutical Specialty Injectable Generics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Par Pharmaceutical Specialty Injectable Generics Sales Growth Rate (2012-2017)
Figure Par Pharmaceutical Specialty Injectable Generics Sales Market Share in United States (2012-2017)
Figure Par Pharmaceutical Specialty Injectable Generics Revenue Market Share in United States (2012-2017)
Table Sagent Pharmaceuticals Basic Information List
Table Sagent Pharmaceuticals Specialty Injectable Generics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sagent Pharmaceuticals Specialty Injectable Generics Sales Growth Rate (2012-2017)
Figure Sagent Pharmaceuticals Specialty Injectable Generics Sales Market Share in United States (2012-2017)
Figure Sagent Pharmaceuticals Specialty Injectable Generics Revenue Market Share in United States (2012-2017)
Table Teligent Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Specialty Injectable Generics
Figure Manufacturing Process Analysis of Specialty Injectable Generics
Figure Specialty Injectable Generics Industrial Chain Analysis
Table Raw Materials Sources of Specialty Injectable Generics Major Players/Suppliers in 2016
Table Major Buyers of Specialty Injectable Generics
Table Distributors/Traders List
Figure United States Specialty Injectable Generics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Specialty Injectable Generics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Specialty Injectable Generics Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Specialty Injectable Generics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Specialty Injectable Generics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Specialty Injectable Generics Sales Volume (K Units) Forecast by Type in 2022
Table United States Specialty Injectable Generics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Specialty Injectable Generics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Specialty Injectable Generics Sales Volume (K Units) Forecast by Application in 2022
Table United States Specialty Injectable Generics Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Specialty Injectable Generics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Specialty Injectable Generics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Specialty Injectable Generics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources